Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Expression of two testis-specific genes, TSGA10 and SYCP3, in different cancers regarding to their pathological features.

Mobasheri MB, Jahanzad I, Mohagheghi MA, Aarabi M, Farzan S, Modarressi MH.

Cancer Detect Prev. 2007;31(4):296-302.

PMID:
17920210
2.

Over-expression of the testis-specific gene TSGA10 in cancers and its immunogenicity.

Tanaka R, Ono T, Sato S, Nakada T, Koizumi F, Hasegawa K, Nakagawa K, Okumura H, Yamashita T, Ohtsuka M, Asagoe K, Yamasaki O, Noguchi Y, Iwatsuki K, Nakayama E.

Microbiol Immunol. 2004;48(4):339-45.

3.

Testicular expression of synaptonemal complex protein 3 (SYCP3) messenger ribonucleic acid in 110 patients with nonobstructive azoospermia.

Aarabi M, Modarressi MH, Soltanghoraee H, Behjati R, Amirjannati N, Akhondi MM.

Fertil Steril. 2006 Aug;86(2):325-31. Epub 2006 Jul 5.

PMID:
16824523
4.

Expression of the testis-specific gene, TSGA10, in Iranian patients with acute lymphoblastic leukemia (ALL).

Mobasheri MB, Modarressi MH, Shabani M, Asgarian H, Sharifian RA, Vossough P, Shokri F.

Leuk Res. 2006 Jul;30(7):883-9. Epub 2006 Jan 6.

PMID:
16406020
5.

Identification of a new cancer/testis gene family, CT47, among expressed multicopy genes on the human X chromosome.

Chen YT, Iseli C, Venditti CA, Old LJ, Simpson AJ, Jongeneel CV.

Genes Chromosomes Cancer. 2006 Apr;45(4):392-400.

PMID:
16382448
6.

TSGA10 is Specifically Expressed in Astrocyte and Over-expressed in Brain Tumors.

Behnam B, Chahlavi A, Pattisapu J, Wolfe J.

Avicenna J Med Biotechnol. 2009 Oct;1(3):161-6.

7.
8.

Identification of endogenous reference genes for qRT-PCR analysis in normal matched breast tumor tissues.

Gur-Dedeoglu B, Konu O, Bozkurt B, Ergul G, Seckin S, Yulug IG.

Oncol Res. 2009;17(8):353-65.

PMID:
19544972
9.

Expression of Tsga10 sperm tail protein in embryogenesis and neural development: from cilium to cell division.

Behnam B, Modarressi MH, Conti V, Taylor KE, Puliti A, Wolfe J.

Biochem Biophys Res Commun. 2006 Jun 16;344(4):1102-10. Epub 2006 Apr 21.

PMID:
16643851
10.

CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.

Zabouo G, Imbert AM, Jacquemier J, Finetti P, Moreau T, Esterni B, Birnbaum D, Bertucci F, Chabannon C.

Breast Cancer Res. 2009;11(1):R1. doi: 10.1186/bcr2215. Epub 2009 Jan 5.

11.

Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling.

Yang YH, Deng H, Li WM, Zhang QY, Hu XT, Xiao B, Zhu HH, Geng PL, Lu YY.

Clin Cancer Res. 2008 Jan 1;14(1):74-81. doi: 10.1158/1078-0432.CCR-07-1179.

12.

Tsga10 encodes a 65-kilodalton protein that is processed to the 27-kilodalton fibrous sheath protein.

Modarressi MH, Behnam B, Cheng M, Taylor KE, Wolfe J, van der Hoorn FA.

Biol Reprod. 2004 Mar;70(3):608-15. Epub 2003 Oct 29.

13.

Structural components of the synaptonemal complex, SYCP1 and SYCP3, in the medaka fish Oryzias latipes.

Iwai T, Yoshii A, Yokota T, Sakai C, Hori H, Kanamori A, Yamashita M.

Exp Cell Res. 2006 Aug 1;312(13):2528-37. Epub 2006 May 6.

PMID:
16764855
14.

The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 beta-1,6-N-acetylglucosaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas.

St Hill CA, Farooqui M, Mitcheltree G, Gulbahce HE, Jessurun J, Cao Q, Walcheck B.

BMC Cancer. 2009 Mar 6;9:79. doi: 10.1186/1471-2407-9-79.

15.

Genes overexpressed in different human solid cancers exhibit different tissue-specific expression profiles.

Axelsen JB, Lotem J, Sachs L, Domany E.

Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):13122-7. Epub 2007 Jul 30. Erratum in: Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):15168. Bock-Axelsen, Jacob [corrected to Bock, Jacob Bock].

16.

N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.

Melotte V, Lentjes MH, van den Bosch SM, Hellebrekers DM, de Hoon JP, Wouters KA, Daenen KL, Partouns-Hendriks IE, Stessels F, Louwagie J, Smits KM, Weijenberg MP, Sanduleanu S, Khalid-de Bakker CA, Oort FA, Meijer GA, Jonkers DM, Herman JG, de Bruïne AP, van Engeland M.

J Natl Cancer Inst. 2009 Jul 1;101(13):916-27. doi: 10.1093/jnci/djp131. Epub 2009 Jun 17.

PMID:
19535783
17.

Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.

Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ.

Breast Cancer Res Treat. 2009 Sep;117(1):45-54. doi: 10.1007/s10549-008-0163-6. Epub 2008 Sep 13.

PMID:
18791823
18.

Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.

Feng W, Marquez RT, Lu Z, Liu J, Lu KH, Issa JP, Fishman DM, Yu Y, Bast RC Jr.

Cancer. 2008 Apr 1;112(7):1489-502. doi: 10.1002/cncr.23323.

19.

Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.

Veeck J, Noetzel E, Bektas N, Jost E, Hartmann A, Knüchel R, Dahl E.

Mol Cancer. 2008 Nov 6;7:83. doi: 10.1186/1476-4598-7-83.

20.

Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers.

Bakkum-Gamez JN, Aletti G, Lewis KA, Keeney GL, Thomas BM, Navarro-Teulon I, Cliby WA.

Gynecol Oncol. 2008 Jan;108(1):141-8. Epub 2007 Nov 7.

PMID:
17988723

Supplemental Content

Support Center